Arca
Skip to content

Nuvasive Coroent System

Intervertebral Fusion Device With Bone Graft, Lumbar. 510(k) K071795, from Nuvasive, Inc. (San Diego, CA). Product code MAX, class 2.

As of Nov 17, 2026, K071795 is an FDA 510(k) held by Nuvasive, Inc., substantially equivalent on Dec 4, 2007 after 155 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Dec 4, 2007
  • Review time: 155 days
  • Recalls: 0
  • Cited as a predicate by: 42 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

Intervertebral Body Fusion The NuVasive CoRoent System is indicated for intervertebral body fusion of the spine in skeletally mature patients. The System is designed for use with autogenous bone graft to facilitate fusion.

Cited as a Predicate

42 later 510(k) summaries name this device as a predicate; the 12 newest

Other MAX Clearances

The newest 510(k)s for the same product code; their median review was 142 days; see every MAX device

Record

Type
Abbreviated
Received
Jul 2, 2007
Review panel
Orthopedic
Regulation
21 CFR 888.3080

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.